Table 2.

Transplantations: Clinical Data

Characteristic CY/GM/BM MAC/G/PB CY/G/PB
Mobilization* 
 Time to WBC   >700-1,000  3-19; 15 13-35; 18  9-19; 16 
 CD34+ × 106 cells/kg  Not done  2.1-114; 5.8  1.5-7; 3.8  
 CFC (× 104)/kg  2.3-145; 6.7  2.7-161; 38 12-85; 61  
 LTC-IC (× 103)/kg  0.35-12; 5.4 0.5-21; 3.2  1-10; 6  
 
Transplantation  
 
Time to engraftment* 
 WBC  9-33; 13  9-18; 11  2-11; 10 
 Platelet  12->100; 37  15-49; 21  15-21; 19 
 RBC  22->100; 41  16-51; 30  25-46; 29 
Survival 
 1-year survival 80% (60%-100%)  86% (68%-100%)  NA 
Characteristic CY/GM/BM MAC/G/PB CY/G/PB
Mobilization* 
 Time to WBC   >700-1,000  3-19; 15 13-35; 18  9-19; 16 
 CD34+ × 106 cells/kg  Not done  2.1-114; 5.8  1.5-7; 3.8  
 CFC (× 104)/kg  2.3-145; 6.7  2.7-161; 38 12-85; 61  
 LTC-IC (× 103)/kg  0.35-12; 5.4 0.5-21; 3.2  1-10; 6  
 
Transplantation  
 
Time to engraftment* 
 WBC  9-33; 13  9-18; 11  2-11; 10 
 Platelet  12->100; 37  15-49; 21  15-21; 19 
 RBC  22->100; 41  16-51; 30  25-46; 29 
Survival 
 1-year survival 80% (60%-100%)  86% (68%-100%)  NA 

Abbreviation: NA, not applicable.

*

Results are shown as range; median.

Results are actuarial survival at 1 year (95% CI).

or Create an Account

Close Modal
Close Modal